Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
THMO | F | ThermoGenesis Holdings, Inc. | -18.65 | |
MEIP | F | MEI Pharma, Inc. | 1.08 | |
CPIX | F | Cumberland Pharmaceuticals Inc. | 0.70 | |
SLRX | F | Salarius Pharmaceuticals, Inc. | -20.51 | |
TCON | F | TRACON Pharmaceuticals, Inc. | -41.07 | |
VTGN | F | VistaGen Therapeutics, Inc. | 12.36 | |
ATRA | F | Atara Biotherapeutics, Inc. | 12.53 | |
ONCT | F | Oncternal Therapeutics, Inc. | -0.82 | |
EQ | F | Equillium, Inc. | 3.98 | |
LIXT | F | Lixte Biotechnology Holdings, Inc. | 4.87 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Cancer
Biopharmaceutical
Sarcoma
Solid Tumors
Drugs
Treatment Of Cancer
Biology
Biotechnology
Breast Cancer
Clinical Medicine
Clinical Trial
Drug Discovery
Immune Checkpoint
Monoclonal Antibody
Ovarian Cancer
Targeted Therapy
Treatment Of Breast Cancer
Advanced Solid Tumors
Age Related Macular Degeneration
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | A | Simplify Health Care ETF | 10.39 | |
BBP | B | BioShares Biotechnology Products Fund | 5.61 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 5.45 | |
BTEC | B | Principal Healthcare Innovators Index ETF | 5.19 | |
GNOM | C | Global X Genomics & Biotechnology ETF | 4.99 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Medicine
Cancer
Biology
Cystic Fibrosis
Disease
IBD 50
Idiopathic Pulmonary Fibrosis
Oncology
Organ Systems
Pulmonary Fibrosis
Rare Diseases
Treatment Of Idiopathic Pulmonary Fibrosis
Acute Intermittent Porphyria
Adeno Associated Virus
Alipogene Tiparvovec
Alzheimer's Disease
Antibody Drug Conjugate
Antidepressants
Antisense RNA
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles